196 related articles for article (PubMed ID: 19439922)
1. Gorlin syndrome patient with large deletion in 9q22.32-q22.33 detected by quantitative multiplex fluorescent PCR.
Musani V; Cretnik M; Situm M; Basta-Juzbasic A; Levanat S
Dermatology; 2009; 219(2):111-8. PubMed ID: 19439922
[TBL] [Abstract][Full Text] [Related]
2. Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature.
Yamamoto K; Yoshihashi H; Furuya N; Adachi M; Ito S; Tanaka Y; Masuno M; Chiyo H; Kurosawa K
Congenit Anom (Kyoto); 2009 Mar; 49(1):8-14. PubMed ID: 19243411
[TBL] [Abstract][Full Text] [Related]
3. NBCCS secondary to an interstitial chromosome 9q deletion.
Haniffa MA; Leech SN; Lynch SA; Simpson NB
Clin Exp Dermatol; 2004 Sep; 29(5):542-4. PubMed ID: 15347344
[TBL] [Abstract][Full Text] [Related]
4. A YAC contig spanning the nevoid basal cell carcinoma syndrome, Fanconi anaemia group C, and xeroderma pigmentosum group A loci on chromosome 9q.
Morris DJ; Reis A
Genomics; 1994 Sep; 23(1):23-9. PubMed ID: 7829076
[TBL] [Abstract][Full Text] [Related]
5. Physical mapping of the 5 Mb D9S196-D9S180 interval harboring the basal cell nevus syndrome gene and localization of six genes in this region.
Xie J; Quinn A; Zhang X; Bare J; Rothman A; Collins C; Cutone S; Rutter M; McCormick MK; Epstein E
Genes Chromosomes Cancer; 1997 Apr; 18(4):305-9. PubMed ID: 9087571
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients.
Shimkets R; Gailani MR; Siu VM; Yang-Feng T; Pressman CL; Levanat S; Goldstein A; Dean M; Bale AE
Am J Hum Genet; 1996 Aug; 59(2):417-22. PubMed ID: 8755929
[TBL] [Abstract][Full Text] [Related]
7. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
8. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
[TBL] [Abstract][Full Text] [Related]
9. Perinatal findings and molecular cytogenetic analyses of de novo interstitial deletion of 9q (9q22.3-->q31.3) associated with Gorlin syndrome.
Chen CP; Lin SP; Wang TH; Chen YJ; Chen M; Wang W
Prenat Diagn; 2006 Aug; 26(8):725-9. PubMed ID: 16927391
[TBL] [Abstract][Full Text] [Related]
10. Microdeletion 9q22.3 syndrome includes metopic craniosynostosis, hydrocephalus, macrosomia, and developmental delay.
Muller EA; Aradhya S; Atkin JF; Carmany EP; Elliott AM; Chudley AE; Clark RD; Everman DB; Garner S; Hall BD; Herman GE; Kivuva E; Ramanathan S; Stevenson DA; Stockton DW; Hudgins L
Am J Med Genet A; 2012 Feb; 158A(2):391-9. PubMed ID: 22190277
[TBL] [Abstract][Full Text] [Related]
11. Delineation of an interstitial 9q22 deletion in basal cell nevus syndrome.
Boonen SE; Stahl D; Kreiborg S; Rosenberg T; Kalscheuer V; Larsen LA; Tommerup N; Brøndum-Nielsen K; Tümer Z
Am J Med Genet A; 2005 Jan; 132A(3):324-8. PubMed ID: 15690381
[TBL] [Abstract][Full Text] [Related]
12. Williams-Beuren syndrome: determination of deletion size using quantitative real-time PCR.
Schubert C; Laccone F
Int J Mol Med; 2006 Nov; 18(5):799-806. PubMed ID: 17016608
[TBL] [Abstract][Full Text] [Related]
13. A two-hit model for developmental defects in Gorlin syndrome.
Levanat S; Gorlin RJ; Fallet S; Johnson DR; Fantasia JE; Bale AE
Nat Genet; 1996 Jan; 12(1):85-7. PubMed ID: 8528259
[No Abstract] [Full Text] [Related]
14. Fine genetic mapping of the gene for nevoid basal cell carcinoma syndrome.
Wicking C; Berkman J; Wainwright B; Chenevix-Trench G
Genomics; 1994 Aug; 22(3):505-11. PubMed ID: 8001963
[TBL] [Abstract][Full Text] [Related]
15. [The Gorlin syndrome. A review of 11 cases].
Alegre M; Puig L; de Moragas JM
Rev Clin Esp; 1995 Oct; 195(10):684-7. PubMed ID: 8532924
[TBL] [Abstract][Full Text] [Related]
16. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype.
Asmus F; Hjermind LE; Dupont E; Wagenstaller J; Haberlandt E; Munz M; Strom TM; Gasser T
Brain; 2007 Oct; 130(Pt 10):2736-45. PubMed ID: 17898012
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.
Delahaye A; Toutain A; Aboura A; Dupont C; Tabet AC; Benzacken B; Elion J; Verloes A; Pipiras E; Drunat S
Eur J Med Genet; 2009; 52(5):328-32. PubMed ID: 19454329
[TBL] [Abstract][Full Text] [Related]
18. A girl with deletion 9q22.1-q22.32 including the PTCH and ROR2 genes identified by genome-wide array-CGH.
Nowakowska B; Kutkowska-Kaźmierczak A; Stankiewicz P; Bocian E; Obersztyn E; Ou Z; Cheung SW; Cai WW
Am J Med Genet A; 2007 Aug; 143A(16):1885-9. PubMed ID: 17632781
[TBL] [Abstract][Full Text] [Related]
19. Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.
Ewing AD; Cheetham SW; McGill JJ; Sharkey M; Walker R; West JA; West MJ; Summers KM
Am J Med Genet A; 2021 Jul; 185(7):2070-2083. PubMed ID: 33960642
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of microdeletion 9q22.3 (pat).
Shimojima K; Adachi M; Tanaka M; Tanaka Y; Kurosawa K; Yamamoto T
Clin Genet; 2009 Apr; 75(4):384-93. PubMed ID: 19320658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
